Multiple myeloma:: Increase of the effectiveness of Velcade® (Bortezomib) through combination therapy

被引：0
|
作者：
不详
机构：
来源：
ONKOLOGIE | 2005年 / 28卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [41] A Cost-Benefit Analysis of Bortezomib, Lenalidomide, and Bortezomib/Lenalidomide Combination Therapy for Newly Diagnosed Multiple Myeloma
    Fiala, Mark A.
    Wildes, Tanya M.
    Shah, Gunjan L.
    Ghobadi, Armin
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    BLOOD, 2017, 130
  • [42] Bortezomib in combination with dexamethasone for relapsed multiple myeloma.
    Kropff, MH
    Bisping, G
    Wenning, D
    Berdel, WE
    Kienast, J
    BLOOD, 2004, 104 (11) : 313B - 313B
  • [43] Velcade - Bortezomib for injection - Millennium - Multiple myeloma treatment represents new class: proteasome inhibitori
    不详
    FORMULARY, 2003, 38 (06) : 346 - +
  • [44] Bortezomib (velcade) for refractory/relapsed multiple myeloma-results of Czech myeloma group (CMG) and Slovak myeloma society (SMS)
    Spicka, I.
    Kotoucek, P.
    Pour, L.
    Tothova, E.
    Maisnar, V.
    Masarova, K.
    Gregora, E.
    Flochova, E.
    Zemanova, M.
    Markuljak, I.
    Adam, Z.
    Hajek, R.
    Mistrik, M.
    Nohejlova, A.
    Scudla, V.
    Straub, J.
    Svorcova, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 166 - 166
  • [45] Venetoclax in Combination With Bortezomib, Dexamethasone, and Daratumumab for Multiple Myeloma
    Rahbari, Kian J.
    Nosrati, Jason D.
    Spektor, Tanya M.
    Berenson, James R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (09): : E339 - E343
  • [46] Bortezomib therapy alone and in combination with dexamethasone for patients with previously untreated multiple myeloma.
    Jagannath, S
    Durie, B
    Wolf, J
    Camacho, E
    Irwin, D
    Lutzky, J
    McKinley, M
    Gabayan, E
    Mazumder, A
    Crowley, J
    Vescio, R
    Schenkein, D
    BLOOD, 2005, 106 (11) : 231A - 231A
  • [47] Bortezomib, liposomal doxorubicin and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma
    Falcone, A.
    Sanpaolo, G.
    Bodenizza, C.
    Carella, A. M.
    Dell'Olio, M.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Scalzulli, F.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 147 - 148
  • [48] Ocular Complications of Bortezomib Therapy in Multiple Myeloma
    Puri, Sonam
    Joshi, Jitesh
    Derman, Olga
    Kornblum, Noah
    Verma, Amit
    Braunschweig, Ira
    Battini, Ramakrishna
    BLOOD, 2014, 124 (21)
  • [49] Chalazia Associated with Bortezomib Therapy for Multiple Myeloma
    Grob, Seanna R.
    Jakobiec, Frederick A.
    Rashid, Alia
    Yoon, Michael K.
    OPHTHALMOLOGY, 2014, 121 (09) : 1845 - 1847
  • [50] Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    BLOOD, 2011, 118 (21) : 1266 - 1267
12345